Pasithea Therapeutics KTTAW
NASDAQ KTTAW
$0.00 0.00 (-36.36%)
As of: Sep 9, 2026 · 3:56 PM EDT

Pasithea Therapeutics Corp. (KTTAW) Liabilities from Discontinued Operations (2022 - 2023)

Pasithea Therapeutics' (KTTAW) quarterly Liabilities from Discontinued Operations came in at $299669.0 in Q1 2023, down 6.23% quarter-over-quarter from $319575.0 in Q4 2022.

Analysis

Pasithea Therapeutics Corp. (KTTAW) Liabilities from Discontinued Operations (2022 - 2023) Analysis & Trends

Pasithea Therapeutics has disclosed Liabilities from Discontinued Operations across 2 years of filings, most recently posting $299669.0 for Q1 2023.

  • In Q1 2023, Liabilities from Discontinued Operations changed N/A year-over-year to $299669.0; the TTM figure through Mar 2023 stood at $299669.0 (changed N/A YoY), while the FY2022 annual figure was $319575.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations came in at $299669.0 for Q1 2023 at Pasithea Therapeutics, down from $319575.0 in the prior quarter.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of $319575.0 in Q4 2022 to a low of $299669.0 in Q1 2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 299,669.00
Dec 31, 2022 319,575.00